A COVID-19 booster shot may provide protection for years, studies find
A range of new studies suggest that a COVID-19 booster shot may provide protection against future variants for many months, even years, The New York Times reports. A recent study posted on bioRxiv, for instance, suggests that a third Pfizer-BioNTech or Moderna shot helps to produce antibodies that could be effective against yet-unseen mutations — even though the vaccines were "not specifically designed to protect against variants." "If people are exposed to another variant like Omicron, they now got some extra ammunition to fight it," Dr. Julie McElrath, a Seattle infectious disease physician, told the Times.
The new findings are similar to those found in the wake of the SARS epidemic that swept across Asia in 2003; one study found that people exposed to SARS at the time were still producing T cells — specialized immune cells — 17 years later. "Memory responses can last for ages," Wendy Burgers, an immunologist at the University of Cape Town, also told the Times. "Potentially, the T-cell response is extremely long-lived."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Jacob Lambert is the art director of TheWeek.com. He was previously an editor at MAD magazine, and has written and illustrated for The Philadelphia Inquirer, Philadelphia Weekly, and The Millions.
-
5 ballsy cartoons about the new White House ballroomCartoons Artists take on the White House Disneyland, a menu for the elites, and more
-
‘Congratulations on your house, but maybe try a greyhound instead’Instant Opinion Opinion, comment and editorials of the day
-
How climate change poses a national security threatThe explainer A global problem causing more global problems
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
